Career history of Robert Francis Doman
Former positions of Robert Francis Doman
Companies | Position | Start | End |
---|---|---|---|
Celsus Therapeutics Plc
Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Celsus Therapeutics Plc is a drug development company, which focuses on developing novel, first-in-class, non-steroidal, synthetic anti-inflammatory drugs and multi-functional anti-inflammatory drugs. The company main clinical candidates are MRX-5, MRX-6, MRX-4, CFX-1 and OPX-1. Celsus Therapeutics was founded on October 7, 2004 and is headquartered in London, the United Kingdom. | Director/Board Member | 30/04/2013 | 14/07/2015 |
Independent Dir/Board Member | 30/04/2013 | 14/07/2015 | |
Leach Technology Group, Inc.
Leach Technology Group, Inc. Medical SpecialtiesHealth Technology Part of TransDigm Group, Inc., Leach Technology Group, Inc. is a manufacturer of medical equipment. The company is based in Indianapolis, IN. | President | 31/12/1999 | 31/12/2003 |
WEST PHARMACEUTICAL SERVICES, INC. | Corporate Officer/Principal | 31/12/1998 | 31/12/1999 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 31/12/1990 | 31/12/1998 |
ECHO THERAPEUTICS, INC. | Director/Board Member | 12/03/2013 | 25/08/2013 |
Chief Executive Officer | 25/08/2013 | 29/06/2014 | |
Chairman | 25/08/2013 | - | |
DUSA Pharmaceuticals, Inc.
DUSA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company, which develops and markets Levulan Photodynamic Therapy technology platform for the prevention and treatment of dermatological skin conditions. Its products include levulan kerastick, BLU-U and clindareach. The company was founded by D. Geoffrey Shulman on February 21, 1991 and is headquartered in Wilmington, MA. | Director/Board Member | 12/06/2011 | - |
President | 31/12/2004 | - |
Training of Robert Francis Doman
St. Joseph's University | Undergraduate Degree |
Statistics
International
United States | 7 |
United Kingdom | 2 |
Operational
Director/Board Member | 3 |
President | 2 |
Corporate Officer/Principal | 2 |
Sectoral
Health Technology | 7 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
WEST PHARMACEUTICAL SERVICES, INC. | Health Technology |
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
Private companies | 4 |
---|---|
DUSA Pharmaceuticals, Inc.
DUSA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company, which develops and markets Levulan Photodynamic Therapy technology platform for the prevention and treatment of dermatological skin conditions. Its products include levulan kerastick, BLU-U and clindareach. The company was founded by D. Geoffrey Shulman on February 21, 1991 and is headquartered in Wilmington, MA. | Health Technology |
Leach Technology Group, Inc.
Leach Technology Group, Inc. Medical SpecialtiesHealth Technology Part of TransDigm Group, Inc., Leach Technology Group, Inc. is a manufacturer of medical equipment. The company is based in Indianapolis, IN. | Health Technology |
Echo Therapeutics, Inc.
Echo Therapeutics, Inc. Medical SpecialtiesHealth Technology Echo Therapeutics, Inc. is a medical device company, which engages in the development of non-invasive, and wireless continuous glucose monitoring system for use in the diabetes outpatient market. It offers needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose and delivery of topical pharmaceuticals. The company was founded in 1989 and is headquartered in Iselin, NJ. | Health Technology |
Celsus Therapeutics Plc
Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Celsus Therapeutics Plc is a drug development company, which focuses on developing novel, first-in-class, non-steroidal, synthetic anti-inflammatory drugs and multi-functional anti-inflammatory drugs. The company main clinical candidates are MRX-5, MRX-6, MRX-4, CFX-1 and OPX-1. Celsus Therapeutics was founded on October 7, 2004 and is headquartered in London, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Robert Francis Doman
- Experience